Phreesia Price to Book Ratio 2019-2024 | PHR
Historical price to book ratio values for Phreesia (PHR) over the last 10 years. The current price to book ratio for Phreesia as of May 10, 2024 is 4.73.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Phreesia Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-10 | 21.37 | 4.79 | |
| 2024-01-31 | 25.48 | $4.46 | 5.71 |
| 2023-10-31 | 13.66 | $4.76 | 2.87 |
| 2023-07-31 | 31.72 | $4.57 | 6.94 |
| 2023-04-30 | 31.64 | $4.92 | 6.43 |
| 2023-01-31 | 37.49 | $5.41 | 6.93 |
| 2022-10-31 | 27.32 | $6.08 | 4.50 |
| 2022-07-31 | 23.49 | $6.64 | 3.54 |
| 2022-04-30 | 22.88 | $7.31 | 3.13 |
| 2022-01-31 | 31.19 | $8.06 | 3.87 |
| 2021-10-31 | 70.54 | $8.96 | 7.88 |
| 2021-07-31 | 68.35 | $9.59 | 7.13 |
| 2021-04-30 | 51.75 | $10.04 | 5.16 |
| 2021-01-31 | 65.29 | $5.88 | 11.10 |
| 2020-10-31 | 36.97 | $6.12 | 6.04 |
| 2020-07-31 | 30.06 | $2.58 | 11.66 |
| 2020-04-30 | 25.39 | $2.66 | 9.55 |
| 2020-01-31 | 31.00 | $2.78 | 11.14 |
| 2019-10-31 | 29.63 | $2.86 | 10.37 |
| 2019-07-31 | 27.33 | $2.88 | 9.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.205B | $0.356B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.069B | 20.90 |
| Inspire Medical Systems (INSP) | United States | $4.986B | 0.00 |
| Axonics (AXNX) | United States | $3.440B | 0.00 |
| 10x Genomics (TXG) | United States | $3.097B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.080B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.900B | 0.00 |
| Azenta (AZTA) | United States | $2.877B | 156.36 |
| Enovis (ENOV) | United States | $2.801B | 20.76 |
| Hims & Hers Health (HIMS) | United States | $2.633B | 0.00 |
| Privia Health (PRVA) | United States | $2.132B | 119.80 |
| Schrodinger (SDGR) | United States | $1.644B | 0.00 |
| Omnicell (OMCL) | United States | $1.383B | 47.81 |
| Standard BioTools (LAB) | United States | $0.696B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.651B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.627B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.406B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.378B | 0.00 |
| Pulmonx (LUNG) | United States | $0.326B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.306B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.215B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Outset Medical (OM) | United States | $0.159B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| TruBridge (TBRG) | United States | $0.129B | 7.07 |
| MSP Recovery (LIFW) | United States | $0.121B | 0.00 |
| Augmedix (AUGX) | United States | $0.109B | 0.00 |
| 111 (YI) | China | $0.095B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.078B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| CareCloud (CCLD) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |